Strathclyde Institute of Medical Devices (SIMD), is a business/clinical engagement and commercialisation vehicle for medical technologies, including  sensors, emerging from the University of Strathclyde - not least its long established EPSRC Centre for Doctoral Training in Medical Devices and Health Technologies.

SIMD’s role is in supporting the translation of medical technology research into clinical and commercial outcomes.

Our medical technology sensor interests encompass  point of care diagnostics (POC), particularly non or minimally  invasive electronic sensor systems. We have commercialised POC systems on wound hydration monitoring and developed a system for monitoring wound pH and tested it in Qatar.

We have developed, and in some cases conducted clinical studies on, transdermal POC systems. A range of small molecules (glucose, lactate, vitamins) and ions can be continuously monitored. A recent electrolyte/hydration monitor  based on this technology formed the basis of a wearable device for athletes.

Finally, we have also developed a label and reagent free POC technology for bacterial infection monitoring. At the moment this has been used in the context of Cystic Fibrosis - accurately detecting the presence of Pseudomonas aeruginosa with high specificity - though it is expected that a similar rationale can be applied to other bacterial agents.